Kent O Lillemoe
CIK 1220096 · View on SEC EDGAR ↗
First SEC filing: April 1, 2014 · Latest: April 1, 2014
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 31, 2014 | CREX | A | 2,922 | — | — | 22,470 Direct | +14.95% | Acquired | (price as of 2026-08-21) |
| Jan. 14, 2014 | CREX | A | 60,000 | — | — | 60,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2013 | CREX | A | 3,750 | — | — | 19,548 Direct | +23.74% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2013 | CREX | A | 2,711 | — | — | 15,798 Direct | +20.72% | Acquired | (price as of 2026-08-21) |
| June 28, 2013 | CREX | A | 2,744 | — | — | 13,087 Direct | +26.53% | Acquired | (price as of 2026-08-21) |
| March 29, 2013 | CREX | A | 1,667 | — | — | 10,343 Direct | +19.21% | Acquired | (price as of 2026-08-21) |
| Feb. 13, 2013 | CREX | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2012 | CREX | A | 1,125 | — | — | 8,676 Direct | +14.90% | Acquired | (price as of 2026-08-21) |
| Sept. 28, 2012 | CREX | A | 2,446 | — | — | 37,755 Direct | +6.93% | Acquired | (price as of 2026-08-21) |
| Sept. 13, 2012 | CREX | A | 30,864 | $0.81 | $25,000 | 35,309 Direct | +694.35% | Acquired | -99.2% (price as of 2026-08-21) |
| June 29, 2012 | CREX | A | 2,198 | — | — | 4,445 Direct | +97.82% | Acquired | (price as of 2026-08-21) |
| March 30, 2012 | CREX | A | 2,247 | — | — | 2,247 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 16, 2012 | CREX | A | 32,710 | — | — | 32,710 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 15, 2011 | CREX | A | 40,000 | — | — | 40,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 15, 2011 | CREX | A | 40,000 | — | — | 40,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 14, 2014 | CREX | Stock Option (right to buy) [F1] | Common Stock (60,000) | $0.79 | Jan. 14, 2024 | 60,000 | Acquired |
| Feb. 13, 2013 | CREX | Stock Option (right to buy) [F1] | Common Stock (20,000) | $1.80 | Feb. 13, 2023 | 20,000 | Acquired |
| Feb. 16, 2012 | CREX | Stock Option (right to buy) [F1] | Common Stock (32,710) | $1.07 | Feb. 16, 2022 | 32,710 | Acquired |
| Aug. 15, 2011 | CREX | Stock Option (right to buy) [F1] | Common Stock (40,000) | $1.25 | Aug. 15, 2021 | 40,000 | Acquired |
| Aug. 15, 2011 | CREX | Stock Option (right to buy) [F1] | Common Stock (40,000) | $1.25 | Aug. 15, 2021 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).